KuCoin Launches “Anti-Phishing Month” Campaign, Empowering Users Through Education, Incentives, and Defense

PROVIDENCIALES, Turks and Caicos Islands, Aug. 25, 2025 /PRNewswire/ — KuCoin, a global leading cryptocurrency exchange, announced the official launch of its “Anti-Phishing Month” campaign. The initiative integrates user education, positive incentives, and technical defenses to build a platform-level proactive security framework and enhance user awareness in identifying and preventing phishing scams. Continue Reading In […]

IDEAYA Biosciences to Participate in Upcoming September 2025 Investor Relations Events

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events. Cantor Global Healthcare Conference 2025Wednesday, September 3rd, 2025 at 9:10 AM ET Fireside chat with Yujiro S. Hata, President and […]

Wallarm Report Uncovers AI-Powered APIs Emerging as Prime Target in Q2 2025 API Threat Landscape

SAN FRANCISCO, Aug. 25, 2025 /PRNewswire/ — Wallarm, the leading unified platform for API and agentic AI security, today announced the release of its Q2 2025 API ThreatStats Report. The report offers a deep dive into the evolving API threat landscape, spotlighting a dramatic rise in logic-layer vulnerabilities and threats targeting AI development and orchestration environments. […]

Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy

Topline results anticipated in Q1 2026 and, if successful, planning for expedited NDA submission  If approved, ampreloxetine could address a critical unmet need as the first therapy with the potential to provide durable benefit for the 40,000 patients in the U.S. with symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA) Ampreloxetine has Orphan […]

NEXT Powered by Shulman Rogers named a finalist for the American Lawyer Industry Awards for Legal Services Innovation

POTOMAC, Md., Aug. 25, 2025 /PRNewswire/ — NEXT Powered by Shulman Rogers has been named a finalist in the Legal Services Innovation category for the American Lawyer Industry Awards, which recognize excellence and forward-thinking in the legal profession nationwide.  Continue Reading NEXT powered by Shulman Rogers logo NEXT, the award-winning legal platform designed for startups and early-stage companies, provides fixed-fee legal services, access to seasoned and senior […]

New mtu Series 2000 High Horsepower Engines Produced by MTU Yuchai Power Launched

SINGAPORE, Aug. 25, 2025 /PRNewswire/ — China Yuchai International Limited (NYSE: CYD) (“China Yuchai” or the “Company”), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery Company Limited (“Yuchai”), announced that MTU Yuchai Power Co., Ltd. (“MYP”) successfully launched the first batch of the mtu Series 2000 […]

DYLAN WALSH JOINS 13TH ANNUAL REMEMBER ME THURSDAY® GLOBAL CAUSE

Celebrity Actor and Animal Welfare Advocate Steps Up to Champion Campaign as Featured Luminary  RANCHO SANTA FE, Calif. , Aug. 25, 2025 /PRNewswire/ — In just over 4 weeks, the biggest, global Pet Rescue Awareness Campaign will light up across social media. Over the past thirteen years, Remember Me Thursday® (RMT), observed on the fourth Thursday […]

Fortune Global Forum 2025 to Convene in Riyadh, Saudi Arabia Oct. 26-27

The Global Forum will convene CEOs from Fortune 500 companies, global business leaders, and key policy makers under the theme “The Great Convergence” Confirmed speakers include C-suite leaders from Citigroup, Delta Air Lines, Honeywell, HUMAIN, NYSE, Qualcomm, among others NEW YORK, Aug. 25, 2025 /PRNewswire/ — Fortune announced today that its prestigious Fortune Global Forum […]